Showing 2831-2840 of 7669 results for "".
- Allergan Aesthetics Continues Partnership with Girls Inc.https://practicaldermatology.com/news/allergan-aesthetics-continues-partnership-with-girls-inc/2460869/Allergan Aesthetics is starting its third consecutive year of partnership with Girls Inc. and debuting Empowering Confidence Workshops, a nationwide mentoring initiative. Based on a 2020 Girls Inc. report, many girls have a hard time picturing themselves in science, technology, engineering and mat…
- LiVDerm Brings SBS Part II to Hollywood, FL this Fallhttps://practicaldermatology.com/news/livderm-brings-sbs-part-ii-to-hollywood-fl-this-fall/2460868/SBS Part II: The Aesthetic Dermatology Summit comes to Hollywood, FL, September 23-25, closing out the two-part 19th Annual South Beach Symposium. Produced by LiVDerm, the event is centered on the latest and most relevant information in aesthetic dermatology today with live demonstrations, hands-on…
- Sunscreen Recall: J & J Pulls Five Sunscreens Due to Benzene Contaminationhttps://practicaldermatology.com/news/sunscreen-recall-j-j-pulls-five-sunscreens-due-to-benzene-contamination/2460865/Johnson & Johnson is recalling five Neutrogena and Aveeno aerosol sunscreens after finding low levels of benzene in some samples. The recalled sunscreen products include: AVEENO PROTECT + REFRESH aerosol sunscreen NEUTROGENA Beach Defense aerosol sunscreen NEUTROGENA Cool Dry Sport aerosol su…
- Amgen, International Federation of Psoriasis Associations Launch UPLIFT Innovation Challengehttps://practicaldermatology.com/news/amgen-international-federation-of-psoriasis-associations-launch-uplift-innovation-challenge/2460862/Amgen and the International Federation of Psoriasis Associations are launching the Understanding Psoriatic Disease Leveraging Insights for Treatment (UPLIFT) Innovation Challenge, a new global initiative that aims to foster the development of solutions to address a challenge that people living with…
- Country Singer Jessie James Decker Joins Forces with Geneo to Promote Skincarehttps://practicaldermatology.com/news/country-singer-jessie-james-decker-joins-forces-with-geneo-to-promote-skincare/2460861/Geneo is partnering with country singer Jessie James Decker to promote the importance of skincare and self-care. Geneo is a three-in-one fully customizable facial treatment platform. "I've never been one to get facials in the past but I have noticed over the past couple years and with the natural…
- Arcutis Enrolls First Patient in Phase 3 Trial of Roflumilast for SDhttps://practicaldermatology.com/news/arcutis-enrolls-first-patient-in-phase-3-trial-of-roflumilast-for-sd/2460860/The first patient has been enrolled in the pivotal Phase 3 clinical trial evaluating topical roflumilast foam (ARQ-154) as a potential treatment for seborrheic dermatitis. Arcutis Biotherapeutics, Inc. is developing the once-daily topical foam formulation of roflumilast, a highly potent and selec…
- CeraVe Research Highlights the Impact of UV Exposure on the Skin Barrier and the Benefits of Ceramideshttps://practicaldermatology.com/news/cerave-research-highlights-the-impact-of-uv-exposure-on-the-skin-barrier-and-the-benefits-of-ceramides/2460859/A skincare regimen that includes a moisturizer and sunscreen formulated with ceramides can help protect against ultraviolet(UV)-induced skin barrier damage and improve skin barrier health overall, according to new research in the Journal of Drugs in Dermatology. The clinical study evaluated the …
- StrataGraft Reduces Need for Autografting of Deep Partial-Thickness Burnshttps://practicaldermatology.com/news/stratagraft-reduces-need-for-autografting-of-deep-partial-thickness-burns-strata/2460858/Mallinckrodt plc’s StrataGraft (allogeneic cultured keratinocytes and dermal fibroblasts in murine collagen – dsat) may provide a much-needed alternative to autografting for patients with deep partial-thickness burns, a new study shows. Fully 96 percent of the StrataGraft-treated burn sites across…
- Sirnaomics Doses First Patient in Phase 2b Study of STP705 for Treatment of Squamous Cell Skin Cancerhttps://practicaldermatology.com/news/sirnaomics-doses-first-patient-in-phase-2b-study-of-stp705-for-treatment-of-squamous-cell-skin-cancer/2460857/Sirnaomics, Inc. dosed the first patient in a Phase 2b study of the company's drug candidate, STP705, for the treatment of squamous cell skin cancer in situ (isSCC). The company expects to report interim clinical data of the Phase 2 study in the second half of 2021. STP705 is a siRNA (small inte…
- FDA Approves New Cheek Filler from Galdermahttps://practicaldermatology.com/news/fda-approves-new-cheek-filler-from-galderma/2460856/The U.S. Food and Drug Administration (FDA) approved Galderma’s Restylane Contour for cheek augmentation and correction of midface contour deficiencies in adults over the age of 21. Restylane Contour, a new hyaluronic acid (HA) dermal filler, is Galderma's first and only product in the U.S. formul…